Similar Posts
Adjuvants and Thimerosal (aka Thiomersal)
Adjuvants stimulate increased, nonspecific immunity and are included in many “killed” vaccines. Until October 16, all adjuvants in licensed vaccines in the US were aluminum salts. They are included in tetanus, Hepatitis A and B, anthrax and other killed vaccines. Thimerosal is a compound composed of 50% mercury which has been included in many killed…
WaPo 7/28 publishes multiple truth grenades as well as fake news about breakthrough cases
https://www.washingtonpost.com/health/breakthrough-infections-cdc-data/2021/07/28/dcaaa6b2-efce-11eb-a452-4da5fe48582d_story.html Health CDC reversal on indoor masking prompts experts to ask, ‘Where’s the data?’ Excerpts: New recommendations from federal health officials this week on when vaccinated Americans should don face masks came with a startling bolt of news: People who have had their shots and become infected with the delta variant of the coronavirus can harbor large amounts of virus just like…
Chilling pandemic data from the insurance industry/ Mary Beth Pfeiffer (More on this crucial subject)
https://rescue.substack.com/p/chilling-pandemic-data-from-the-insurance Chilling Pandemic Data from the Insurance Industry A major Indiana-based insurance company reports unprecedented 40 percent death-rate increases industry-wide among working-age Americans in 2021 compared to pre-pandemic data. Mary Beth Pfeiffer Jan 5 This article is part of a publishing collaboration between Rescue and Trial Site News. The outstanding reporting by Mary Beth Pfeiffer will be…
Coronavirus: Mortality rates, hidden information. Part 2
There are so many questions. But so few answers. So little to go on. No workable Plan B in sight. When to reopen the economy? When to send children back to school? Will there be a second wave, or even a third wave, as occurred with the 1918 swine flu pandemic? Those questions demand answers,…
Officials recall more swine flu vaccine/ SF Chronicle
Millions more doses of swine flu vaccine were recalled this week after routine tests found they weren’t strong enough to meet minimum public health standards for protection against the virus. In a previous post, I cited literature that showed the nasal vaccine had been only 29% effective in adults in a previous year, even when…
H1N1 vaccines with novel adjuvants being developed for potential mass use
The US government has contracted with at least 5 pharmaceutical manufacturers to develop and produce H1N1 vaccines, using a variety of platforms and manufacturing methods. This is an excellent approach, since at this point no one knows which will succeed and how long it will take to obtain desired quantities of vaccine. A novel feature…